Cofinimmo Past Earnings Performance
Past criteria checks 4/6
Cofinimmo's earnings have been declining at an average annual rate of -21%, while the Health Care REITs industry saw earnings declining at 7.3% annually. Revenues have been growing at an average rate of 4.5% per year. Cofinimmo's return on equity is 5.7%, and it has net margins of 52.9%.
Key information
-20.99%
Earnings growth rate
-26.47%
EPS growth rate
| Health Care REITs Industry Growth | 0.61% |
| Revenue growth rate | 4.46% |
| Return on equity | 5.67% |
| Net Margin | 52.91% |
| Next Earnings Update | 23 Jul 2026 |
Recent past performance updates
Recent updates
COFB: Aedifica Merger Path And Index Removal Will Shape Balanced Outlook
Analysts have kept their Cofinimmo price target steady at €86.17, citing only small adjustments to the discount rate, revenue growth assumptions, and profit margin forecasts. Their long-term view remains broadly unchanged.COFB: Index Removal And 2026 Meeting Will Shape Balanced Risk Profile
Analysts have kept their Cofinimmo price target broadly steady at about €86.17, with the latest update reflecting slightly adjusted assumptions on discount rate, revenue growth and profit margin that leave the implied P/E multiple close to prior levels. What's in the News Cofinimmo SA is recorded as having been removed as an index constituent, which may affect how index funds and ETFs with rules-based mandates treat the stock (Key Developments).COFB: Index Exit And Governance Meeting Will Frame Balanced Risk Reward
Analysts have kept their price target for Cofinimmo broadly steady at €86.17. This reflects only marginal tweaks to assumptions on discount rate, revenue growth, profit margin and future P/E, rather than any major shift in their view of the shares.COFB: Buy Upgrade And Margin Confidence Will Shape Future Risk Reward
Analysts have lifted their price target on Cofinimmo to €86.17 from €86.17. The recent upgrade to Buy supports a slightly more constructive view on its margin profile and long term earnings multiple.COFB: Buy Upgrade And Fair Value View Will Frame Future Risk Reward
Analysts have nudged their price target on Cofinimmo higher to €86.17, reflecting updated assumptions on discount rates, a move to modest revenue growth, a slightly lower profit margin, and a higher forward P/E, alongside a recent upgrade to Buy from a major research house. Analyst Commentary Recent research adjustments give you a clearer view of how the market is framing Cofinimmo at the current price target of €86.17 and the revised assumptions on growth, margins, and P/E.COFB: Buy Upgrade And Refined Assumptions Will Shape Future Risk Reward Balance
Analysts have nudged their fair value estimate for Cofinimmo higher from about €83.72 to around €86.17, citing updated assumptions on discount rates, revenue trends and future P/E, in line with the recent Buy rating upgrade from Kepler Cheuvreux. Analyst Commentary Bullish Takeaways Bullish analysts see the fair value increase from about €83.72 to around €86.17 as support for the recent rating upgrade, suggesting the current share price offers some valuation headroom relative to their assumptions.COFB: Rating Upgrade And Refined Assumptions Will Shape Future Risk Reward Balance
Analysts have modestly adjusted their price targets on Cofinimmo, reflecting slight tweaks to discount rate, revenue growth and profit margin assumptions. Some now see greater upside potential following recent positive research updates and upgrades to Buy.COFB: Rating Upgrade And Refined Assumptions Will Support Fair Value
Analysts have nudged their fair value target for Cofinimmo higher from €81.77 to €83.72, citing updated assumptions around discount rates, profit margins and future P/E, alongside recent positive Street research support. Analyst Commentary Recent Street research has taken a more constructive stance on Cofinimmo, reflected in the higher fair value target of €83.72.COFB: Rating Upgrade And Stable Cash Flows Will Support Fair Value
Analysts have nudged their fair value estimate for Cofinimmo from €81.41 to €81.77, citing a modestly lower discount rate and slightly refined revenue, margin and future P/E assumptions following recent positive Street research. Analyst Commentary Street research has turned more constructive on Cofinimmo, with some analysts moving to a more positive stance and the fair value estimate edging up to €81.77.COFB: Stable Metrics Will Support Fair Value As Risk Perception Slightly Eases
Analysts have trimmed their price target on Cofinimmo slightly to €81.41 from €81.86. This reflects a modestly lower projected future price to earnings multiple and a marginally reduced discount rate in their valuation models.COFB: Stable Metrics Will Support Fair Value Amid Slight Profitability Improvement
Narrative Update on Cofinimmo Analysts have modestly raised their price target on Cofinimmo to EUR 81.86, citing a slightly lower implied discount rate and improved projected profit margins, while growth expectations and valuation multiples remain largely unchanged. Valuation Changes Fair Value: Unchanged at €81.86 per share, indicating a stable intrinsic value estimate.COFB: Financial Metrics Consistency Will Support Stable Fair Value Outlook
Analysts have maintained their fair value estimate for Cofinimmo at €81.86, citing consistent forecasted financial metrics and only minimal updates to underlying assumptions. Valuation Changes Fair Value Estimate remains unchanged at €81.86.COFB: Revenue and Profit Margin Trends Will Shape Fair Value Outlook
Analysts have slightly increased their price target for Cofinimmo from €80.92 to €81.86. They cite improved revenue growth projections and a marginally lower discount rate as key factors behind the adjustment.Healthcare Real Estate Shift Will Yield Lasting Value
Strategic focus on healthcare real estate and divesting non-core areas aims to improve revenue and optimize net margins.Shareholders Of Cofinimmo (EBR:COFB) Must Be Happy With Their 64% Return
Stock pickers are generally looking for stocks that will outperform the broader market. And the truth is, you can make...Revenue & Expenses Breakdown
How Cofinimmo makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 26 | 383 | 203 | 11 | 0 |
| 31 Dec 25 | 382 | 213 | 14 | 0 |
| 30 Sep 25 | 390 | 192 | 12 | 0 |
| 30 Jun 25 | 391 | 134 | 13 | 0 |
| 31 Mar 25 | 392 | 111 | 14 | 0 |
| 31 Dec 24 | 392 | 64 | 13 | 0 |
| 30 Sep 24 | 392 | -52 | 12 | 0 |
| 30 Jun 24 | 392 | -41 | 13 | 0 |
| 31 Mar 24 | 391 | -55 | 14 | 0 |
| 31 Dec 23 | 389 | -55 | 14 | 0 |
| 30 Sep 23 | 379 | 49 | 16 | 0 |
| 30 Jun 23 | 379 | 185 | 15 | 0 |
| 31 Mar 23 | 373 | 333 | 14 | 0 |
| 31 Dec 22 | 368 | 483 | 14 | 0 |
| 30 Sep 22 | 367 | 565 | 16 | 0 |
| 30 Jun 22 | 357 | 489 | 14 | 0 |
| 31 Mar 22 | 351 | 382 | 13 | 0 |
| 31 Dec 21 | 343 | 260 | 12 | 0 |
| 30 Sep 21 | 328 | 189 | 15 | 0 |
| 30 Jun 21 | 312 | 155 | 13 | 0 |
| 31 Mar 21 | 276 | 122 | 18 | 0 |
| 31 Dec 20 | 293 | 119 | 10 | 0 |
| 30 Sep 20 | 296 | 170 | 12 | 0 |
| 30 Jun 20 | 266 | 193 | 22 | 0 |
| 31 Mar 20 | 292 | 222 | 9 | 0 |
| 31 Dec 19 | 285 | 205 | 9 | 0 |
| 30 Sep 19 | 241 | 134 | 24 | 0 |
| 30 Jun 19 | 270 | 119 | 8 | 0 |
| 31 Mar 19 | 259 | 105 | 8 | 0 |
| 31 Dec 18 | 263 | 146 | 8 | 0 |
| 30 Sep 18 | 260 | 186 | 8 | 0 |
| 30 Jun 18 | 258 | 170 | 8 | 0 |
| 31 Mar 18 | 264 | 166 | 8 | 0 |
| 31 Dec 17 | 263 | 137 | 8 | 0 |
| 30 Sep 17 | 267 | 121 | 8 | 0 |
| 30 Jun 17 | 267 | 128 | 8 | 0 |
| 31 Mar 17 | 275 | 134 | 8 | 0 |
| 31 Dec 16 | 257 | 97 | 9 | 0 |
| 30 Sep 16 | 253 | 100 | 9 | 0 |
| 30 Jun 16 | 255 | 82 | 9 | 0 |
| 31 Mar 16 | 249 | 110 | 9 | 0 |
| 31 Dec 15 | 255 | 104 | 8 | 0 |
| 30 Sep 15 | 260 | 76 | 8 | 0 |
| 30 Jun 15 | 262 | 66 | 8 | 0 |
Quality Earnings: COFB has high quality earnings.
Growing Profit Margin: COFB's current net profit margins (52.9%) are higher than last year (28.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: COFB's earnings have declined by 21% per year over the past 5 years.
Accelerating Growth: COFB's earnings growth over the past year (83.2%) exceeds its 5-year average (-21% per year).
Earnings vs Industry: COFB earnings growth over the past year (83.2%) exceeded the Health Care REITs industry 68.9%.
Return on Equity
High ROE: COFB's Return on Equity (5.7%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/05/29 12:23 |
| End of Day Share Price | 2026/05/29 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Cofinimmo SA is covered by 20 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Celine Huynh | Barclays |
| Kai Klose | Berenberg |
| Robert Jones | BNP Paribas |